GATC.L vs. MED
GATC.L (GATTACA plc) and MED (Medifast, Inc.) are both stocks. GATC.L operates in Staffing & Employment Services (Industrials), while MED operates in Personal Services (Consumer Cyclical). Over the past 10 years, GATC.L returned -7.65%/yr vs -6.31%/yr for MED. At a 0.01 correlation, their price movements are largely independent.
Performance
GATC.L vs. MED - Performance Comparison
Loading charts...
Different Trading Currencies
GATC.L is traded in GBp, while MED is traded in USD. To make them comparable, the MED values have been converted to GBp using the latest available exchange rates.
Returns By Period
In the year-to-date period, GATC.L achieves a 65.86% return, which is significantly higher than MED's 14.43% return. Over the past 10 years, GATC.L has underperformed MED with an annualized return of -7.65%, while MED has yielded a comparatively higher -6.31% annualized return.
GATC.L
- 1D
- -1.01%
- 1M
- 28.82%
- YTD
- 65.86%
- 6M
- 45.63%
- 1Y
- 88.15%
- 3Y*
- 19.55%
- 5Y*
- -5.34%
- 10Y*
- -7.65%
MED
- 1D
- -0.77%
- 1M
- -2.84%
- YTD
- 14.43%
- 6M
- 11.14%
- 1Y
- -1.27%
- 3Y*
- -47.69%
- 5Y*
- -45.89%
- 10Y*
- -6.31%
GATC.L vs. MED - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
GATC.L GATTACA plc | 65.86% | 9.53% | -40.13% | 120.87% | -49.64% | 73.84% | -37.89% | 20.19% | -64.14% | 18.81% |
MED Medifast, Inc. | 14.43% | -43.71% | -73.33% | -41.42% | -35.45% | 10.40% | 80.71% | -13.17% | 92.91% | 57.43% |
Correlation
The correlation between GATC.L and MED is -0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.02 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.01 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.02 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.00 |
Correlation (All Time) Calculated using the full available price history since Jul 4, 2007 | 0.01 |
Fundamentals
GATC.L:
£47.87M
MED:
$133.17M
GATC.L:
£0.12
MED:
-$1.82
GATC.L:
0.06
MED:
0.38
GATC.L:
1.57
MED:
0.67
GATC.L:
£812.42M
MED:
$346.10M
GATC.L:
£80.57M
MED:
$242.70M
GATC.L:
£9.91M
MED:
-$3.86M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GATC.L vs. MED — Risk / Return Rank
GATC.L
MED
GATC.L vs. MED - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for GATTACA plc (GATC.L) and Medifast, Inc. (MED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| GATC.L | MED | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.96 | ||
| Sortino ratioReturn per unit of downside risk | +2.82 | ||
| Omega ratioGain probability vs. loss probability | 1.49 | 1.03 | +0.45 |
| Calmar ratioReturn relative to maximum drawdown | 4.76 | -0.04 | +4.79 |
| Martin ratioReturn relative to average drawdown | 11.81 | -0.06 | +11.87 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| GATC.L | MED | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.93 | -0.03 | +1.96 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.11 | -1.04 | +0.93 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.15 | -0.13 | -0.02 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.01 | 0.11 | -0.12 |
Drawdowns
GATC.L vs. MED - Drawdown Comparison
The maximum GATC.L drawdown since its inception was -94.19%, roughly equal to the maximum MED drawdown of -96.56%. Use the drawdown chart below to compare losses from any high point for GATC.L and MED.
Loading charts...
Drawdown Indicators
| GATC.L | MED | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.19% | -96.56% | +2.37% |
Max Drawdown (1Y)Largest decline over 1 year | -18.43% | -36.26% | +17.83% |
Max Drawdown (3Y)Largest decline over 3 years | -49.99% | -91.26% | +41.27% |
Max Drawdown (5Y)Largest decline over 5 years | -80.16% | -96.27% | +16.11% |
Max Drawdown (10Y)Largest decline over 10 years | -92.24% | -96.56% | +4.32% |
Current DrawdownCurrent decline from peak | -66.37% | -95.63% | +29.26% |
Average DrawdownAverage peak-to-trough decline | -50.50% | -39.66% | -10.84% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.44% | 20.82% | -13.38% |
Volatility
GATC.L vs. MED - Volatility Comparison
GATTACA plc (GATC.L) has a higher volatility of 21.58% compared to Medifast, Inc. (MED) at 9.17%. This indicates that GATC.L's price experiences larger fluctuations and is considered to be riskier than MED based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GATC.L | MED | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.58% | 9.17% | +12.41% |
Volatility (6M)Calculated over the trailing 6-month period | 38.41% | 32.24% | +6.17% |
Volatility (1Y)Calculated over the trailing 1-year period | 45.40% | 42.74% | +2.66% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 50.04% | 44.44% | +5.60% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 50.90% | 47.43% | +3.47% |
Dividends
GATC.L vs. MED - Dividend Comparison
GATC.L's dividend yield for the trailing twelve months is around 2.26%, while MED has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GATC.L GATTACA plc | 2.26% | 3.33% | 2.94% | 3.42% | 0.00% | 1.09% | 0.00% | 0.00% | 2.82% | 7.56% | 8.33% | 4.29% |
MED Medifast, Inc. | 0.00% | 0.00% | 0.00% | 7.36% | 5.69% | 2.71% | 2.30% | 3.08% | 1.75% | 2.06% | 2.57% | 0.82% |
Financials
GATC.L vs. MED - Financials Comparison
This section allows you to compare key financial metrics between GATTACA plc and Medifast, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GATC.L vs. MED - Profitability Comparison
GATC.L - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, GATTACA plc reported a gross profit of 21.35M and revenue of 212.43M. Therefore, the gross margin over that period was 10.1%.
MED - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Medifast, Inc. reported a gross profit of 51.76M and revenue of 76.04M. Therefore, the gross margin over that period was 68.1%.
GATC.L - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, GATTACA plc reported an operating income of 2.94M and revenue of 212.43M, resulting in an operating margin of 1.4%.
MED - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Medifast, Inc. reported an operating income of -3.30M and revenue of 76.04M, resulting in an operating margin of -4.3%.
GATC.L - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, GATTACA plc reported a net income of 1.75M and revenue of 212.43M, resulting in a net margin of 0.8%.
MED - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Medifast, Inc. reported a net income of -2.12M and revenue of 76.04M, resulting in a net margin of -2.8%.
Frequently Asked Questions
GATC.L and MED have a correlation of -0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for GATC.L and MED
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer